+1 877 705 1914• 24 / 7
HIPAA Compliant
ISO 27001 Certified

Actively Recruiting

Phase 1
Age: 12Years - 45Years
All Genders
ID03918408

Evaluating Safety and Effectiveness of the PXL-Platinum 330 System for Corneal Cross-Linking in Treating Corneal Thinning Conditions in Patients Aged 12 to 45

Led by Pacific Clear Vision Institute · Updated on 2024-11-12

300

Participants Needed

1

Research Sites

52 weeks

Total Duration

AI-Summary

What This Trial Is About

Researchers are evaluating the safety and effectiveness of the Peschke PXL-330 system for treating corneal thinning conditions such as progressive keratoconus, pellucid marginal degeneration, infectious keratitis, and risk of post-refractive corneal ectasia. This phase 1 study involves patients aged 12 to 45 years and aims to assess corneal strengthening using this novel crosslinking technique. Participants will receive epithelial-on corneal crosslinking using the PXL-330 system with pulsed, accelerated UV-A energy delivery. Two treatment groups include one with 18 mW pulsed illumination and another with 9 mW continuous illumination, each for about 10 minutes. The procedure uses riboflavin to load the cornea prior to UV-A exposure. Treatment is followed by monitoring over one year. During the year-long follow-up, patients will have repeated tests including corneal topography to measure corneal shape, visual acuity exams, intraocular pressure checks, and questionnaires about their vision function. The main outcome measured is mean keratometry in diopters at 12 months, with secondary outcomes including best-corrected visual acuity. Safety and vision changes will be closely tracked throughout.

CONDITIONS

Brief Title

Safety and Effectiveness of the PXL-Platinum 330 System for Corneal Cross-Linking

Research Team

B

BALAMURALI AMBATI, MD, PhD

Not the Right Trial for You?

Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.

Already have an account? Log in here